Customer Login

About
Pipeline
- Canine Pipeline
- Clinical Trials
Products
- Zimeta^™ (dipyrone injection)
Technology
- Veterinary Recombinant Biologics
- Manufacturing Process
Education
- Continuing Education
- KINections
Investors
News
- Press Releases
Contact Us
- Contact Us
- Careers
Menu

Test PI PDF Embed

You are here: Home / Test PI PDF Embed

Mirataz_Full_PI

News

Kindred Biosciences to Present at Barclays Global Healthcare Conference and H.C. Wainwright Global Life Sciences ConferenceMarch 2, 2021 - 8:38 am
Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic IndicationFebruary 25, 2021 - 8:06 am
Kindred Biosciences to Present at the BofA Securities Animal Health Virtual SummitFebruary 16, 2021 - 4:05 pm

Events

Event: Kindred Biosciences to Present at the H.C. Wainwright Global Life Sciences ConferenceMarch 2, 2021 - 8:45 am
Event: Kindred Biosciences to Present at the Barclays Global Healthcare ConferenceMarch 2, 2021 - 8:43 am
Event: Kindred Biosciences to Present at the BofA Securities Animal Health Virtual SummitFebruary 16, 2021 - 4:12 pm

$4.56

0.00 (0.00%)

KIN (Common Stock)
Previous Close	Volume
$4.56	0
Intraday High	Intraday Low
$4.67	$4.47
52 Week High	52 Week Low
$11.24	$3.11
Exchange: NASDAQ CM

KindredBio proudly supports
Rabies Free Africa

Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements

© Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010